Voyager Acquisition Corp.
Status: Live Deal
U=S+W/2
W=S@11.50
| IPO Proceeds, $M | $253.00M |
|---|---|
| IPO Date | Aug 9, 2024 |
| CEO | Adeel Rouf |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 100.5% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | VERAXA Biotech |
| Deal Announced | Apr 23, 2025 |
| Deal Size, $M | $1,591.30M |
| Deal Sector | Healthcare |
| Deal Geography | Europe |
| SEC Filings |
www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
VACH
VACHU
VACHW
| Price | $10.57 |
|---|---|
| Last closing price | $10.58 |
| H/L, today | $10.56 / $10.57 |
| Volume, today | 48,093 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.